Molecular Detection of Type II Toxin RelE Gene and Relation with Biofilm Formation in Escherichia Coli
DOI:
https://doi.org/10.30526/39.2.4302Keywords:
Escherichia coli, biofilm, cefotaxime, Toxins and Antitoxins II relEAbstract
Escherichia coli is the principal etiological agent of urinary tract infections (UTIs) and exhibits significant antibiotic resistance, driven by various virulence factors. Fifty E. coli isolates were obtained from 200 urine specimens of patients, and the relE gene was found to be crucial for antibiotic resistance and biofilm formation. This study used cultural and biochemical tests for primary bacterial isolate diagnosis, with the VITEK 2 System for confirmation. Antibiotic susceptibility testing assessed resistance, while the Congo red technique and microtiter plate method evaluated biofilm production. Multiplex PCR was used to detect the relE gene. Fifty isolates were tested by using the Congo red technique; 86% formed black colonies (biofilm producers), while 14% formed pink colonies (non-biofilm producers). The study found a 72% antibiotic resistance rate to cefotaxime among isolates. Minimum inhibitory concentration (MIC) values for cefotaxime only were 512, 64, and 32 µg/mL. Molecular detection of toxin-antitoxin type II genes via multiplex PCR on 22 isolates revealed that 12 (54.45%) possessed the relE gene. The gene expression was measured using quantitative reverse transcription PCR (qRT-PCR) in the presence and absence of sub-MIC concentrations of cefotaxime. The expression of the relE gene showed downregulation in all isolates, and fold changes were 0.1881, 0.2044, and 0.5864, respectively. The study concluded that changes in gene expression may be induced by environmental pressure or antibiotic resistance, suggesting disruption of the regulatory systems that maintain cell stability and persistence. This phenomenon is recognized as a bacterial defense mechanism.
References
1. Khalid A, Aburesha R. Expression of sfa and afa genes in uropathogenic Escherichia coli under probiotic effect. Al-Rafidain J Med Sci. 2024;7(2). https://doi.org/10.54133/ajms.v7i2.1501
2. Shaker MM, Al-Hadrawi HAN. Measuring the effectiveness of antibiotics against Pseudomonas aeruginosa and Escherichia coli isolated from urinary tract infection patients in Al-Najaf City in Iraq. Mater Today Proc. 2023; 80:3196–3199. https://doi.org/10.1016/j.matpr.2021.07.195
3. Mohammed IJ, Naqid IA, Süer HK. Prevalence, antimicrobial susceptibility profile, and the associated risk factors of uropathogenic Escherichia coli among pregnant women in Zakho City, Kurdistan Region, Iraq. Womens Health Bull. 2022;9(1):34–41. https://doi.org/10.30476/whb.2022.93607.1154
4. Mohammed SA, Ibrahim O. Pharmacodynamics analysis of fosfomycin against multidrug resistant E. coli O157:H7 isolated from urinary tract infection. Biochem Cell Arch. 2022;22(1):1785–1791.https://connectjournals.com/file_full_text/3566001H_1785-1791.
5. Naziri Z, Mirinargasi M, Hadiani MR, Haghshenas MR, Sharifi M. Biofilm formation by uropathogenic Escherichia coli: A complicating factor for treatment and recurrence of urinary tract infections. J Hosp Infect. 2021; 117:9–16. https://doi.org/10.1016/j.jhin.2021.08.017
6. Zhang H, Tao S, Chen H, Fang Y, Xu Y, Chen L, Ma F, Liang W. The biological function of the type II toxin–antitoxin system ccdAB in recurrent urinary tract infections. Front Microbiol. 2024;15:1379625.https://doi.org/10.3389/fmicb.2024.1379625
7. Zhang H, Tao S, Chen H, Fang Y, Xu Y, Han AX, Liang W. Type II toxin–antitoxin systems in Escherichia coli. Infect Drug Resist. 2025;18:1083–1096.https://doi.org/10.2147/IDR.S5014851
8. AbdulHameed H, AbdulJabbar A. Isolation, identification, and antibiotic resistance profile distribution of clinical E. coli in Iraqi patients. Eurasian Med Res Period. 2022; 8:116–121. https://www.researchgate.net/publication/361053642
9. Gholami-Ahangaran M, Moravvej AH, Safizadeh Z, Sadeghi Nogoorani V, Zokaei M, Ghasemian SO. The evaluation of ESBL genes and antibiotic resistance rate in Escherichia coli strains isolated from meat and intestinal contents of turkey in Isfahan, Iran. Iran J Vet Res. 2021;22(4):318–325. https://doi.org/10.22099/ijvr.2021.39493.5737
10. Bakshi, P., Bhowmik, A., Ahsan, S., & Alim, S. R. Identification of antibiotic‐resistant pathogens and virulence genes in Escherichia coli isolates from food samples in the Dhaka University campus of Bangladesh. Food Sci Nutr. 2024;12(3):1995–2002. https://doi.org/10.1002/fsn3.3896
11. Jawad AA, Kadhim AJ, Hashim MH. Prevalence of multi-drug resistant Staphylococcus aureus and Escherichia coli isolated from urinary tract. J Med Life Sci. 2024;6(3):410–419. https://doi.org/10.21608/jmals.2024.383094
12. Abdulzahra NA, Ali RA. Isolation and identification of Escherichia coli that cause diarrhea in neonatal calves. SAR J Pathol Microbiol. 2025;6(2):67–69. https://doi.org/10.36346/sarjpm.2025.v06i02.003
13. Rai S, Dash D, Agarwal N. Introducing the new face of CLSI M100 in 2023: An explanatory review. Indian J Med Microbiol. 2023; 46:100432. https://doi.org/10.1016/j.ijmmb.2023.100432
14. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2025. https://clsi.org/shop/standards/m100-ed35/
15. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163-175.https://doi:10.1038/nprot.2007.521
16. Da Silva RTP, Rocha IV, Dantas TF, dos Santos Silva J, da Costa Júnior SD, de Oliveira Luz AC, de Oliveira MBM. Emergence and spread of resistant and biofilm-forming Acinetobacter baumannii in critically ill COVID-19 patients. Microb Pathog. 2024; 197:107078. https://doi.org/10.1016/j.micpath.2024.107078
17. Al-Yozbakee ZM. Evaluation of modified Congo Red Agar for detection of biofilm producing MDR Klebsiella pneumoniae clinical isolates. J Med Genet Clin Biol. 2024;1(8):89–101. https://doi.org/10.61796/jmgcb.v1i8.775
18. Anan M, Abu-El-Azayem A, Elkashef S. Comparison of two in vitro phenotypic methods (Tissue Culture Plate and Congo Red Agar) for detection of biofilm formation by Enterococci. Egypt J Med Microbiol. 2024;33(1):19–23. https://doi.org/10.21608/ejmm.2024.325935
19. Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, Ruzicka F. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. APMIS. 2007;115(8):891–899. https://doi.org/10.1111/j.1600-0463.2007.apm_630.x
20. Taghadosi R, Shakibaie MR, Ghanbarpour R, Hosseini-Nave H. Role of antigen-43 on biofilm formation and horizontal antibiotic resistance gene transfer in non-O157 Shiga toxin-producing Escherichia coli strains. Iran J Microbiol. 2017;9(2):89–96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715282
21. Alshaikh SA, El-Banna T, Sonbol F, Farghali MH. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital. Ann Clin Microbiol Antimicrob 2024;23(1):20. https://doi:10.1186/s12941-024-00679-2.
22. Green MR, Sambrook J. Analysis of DNA by agarose gel electrophoresis. Cold Spring Harb Protoc. 2019;2019(1):pdb. top100388. https://doi.org/10.1101/pdb.top100388
23. Sweedan EG, Shehab ZH, Flayyih MT. Effect of gentamicin and doxycycline on expression of relB and relE genes in Klebsiella pneumoniae. J Adv Biotechnol Exp Ther. 2022;5(3):667–675. https://doi.org/10.5455/jabet.2022.doxycycline-relB-relE
24. Ahmed AT, Hamada TA. Detection of Multidrug Resistance Uropathogenic Escherichia coli in Pregnant Women in Mosul City. Thi-qar Medical Journal. 2025;29(1):46–56. https://doi:10.32792/jmed.2025.2
25. Schembri MA, Kjaergaard K, Klemm P. Global gene expression in Escherichia coli biofilms. Mol Microbiol. 2003;48(1):253–267. https://doi.org/10.1046/j.1365-2958.2003.03432.x
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2⁻ΔΔCT method. Methods. 2001;25(4):402–408. https://doi.org/10.1006/meth.2001.1262
27. Otaiwi MS, Aqeel Muslim Z. Prevalence of bacterial antibiotic resistance pattern among patients with Uropathogenic E. coli in Hilla city, Iraq. Egypt J Bot. 2025;65;39 –46 https://doi.org/10.21608/ejbo.2025.295768.2877
28. Salman HA, Al-Shammari AA, Al-Ali KH, Al-Khazraji BH. Prevalence of multi-antibiotic resistant bacteria isolated from children with urinary tract infection from Baghdad, Iraq. Microbiol Biotechnol Lett. 2022;50(1):147–156. https://doi.org/10.48022/mbl.2110.10011
29. Al-Rubaye T, Al-Shammari HA, Hussein AK, Ahmed SA. Phenotypic and genotypic screening of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community-acquired urinary tract infection. In: 5th Int Conf Biomed Health Sci, Cihan Univ-Erbil; 2024. p. 250–256. https://eprints.cihanuniversity.edu.iq/id/eprint/3398
30. Feng C, Jia H, Yang Q, Zou Q. Genetic evolution of antibiotic resistance and virulence genes in Escherichia coli isolates from a Chinese hospital over a 12-year period. Microorganisms. 2025; 13:954. https://doi.org/10.3390/microorganisms13040954
31. Ahmed SA, Flayyih MT. Detection of yadN, ygiL, and draE genes in ciprofloxacin-resistant uropathogenic Escherichia coli. Iraqi J Sci. 2025;66(3):1025–1036. https://doi.org/10.24996/ijs.2025.66.3.4
32. Kerek Á, Török B, Laczkó L, Somogyi Z, Kardos G, Bányai K, Kaszab E, Bali K, Jerzsele Á. In vitro microevolution and co-selection assessment of amoxicillin and cefotaxime impact on Escherichia coli resistance development. Antibiotics. 2024; 13:247. https://doi.org/10.3390/antibiotics13030247
33. Al Hagbani T, Alzahrani A, Almalki W, Alyahya SA, Alshahrani SM. Cefotaxime-mediated synthesis of gold nanoparticles: characterization and antibacterial activity. Polymers. 2022;14(4):771. https://doi.org/10.3390/polym14040771
34. Ballén V, Cepas V, Ratia C, Gabasa Y, Soto SM. Clinical Escherichia coli: from biofilm formation to new antibiofilm strategies. Microorganisms. 2022;10(6):1103. https://doi.org/10.3390/microorganisms10061103
35. Behzadi P, Urbán E, Gajdács M. Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): an in vitro study. Diseases. 2020;8(2):17. https://doi.org/10.3390/diseases8020017
36. Bhardwaj A. A comparative appraisal of detection of biofilm production caused by uropathogenic Escherichia coli in tropical catheterized patients by three different methods. Asian J Pharm. 2018;12(4); 1445–1450 https://doi.org/10.22377/ajp.v12i04.2949
37. Katongole P, Tumusiime R, Byarugaba DK, Odoi H, Baguma L, Kiggundu R. Biofilm formation, antimicrobial susceptibility and virulence genes of uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infect Dis. 2020; 20:453. https://doi.org/10.1186/s12879-020-05186-1
38. Hasnawi ZAH, Al-Hilu SA. Investigating the relationship between biofilm formation and antibiotic resistance patterns of Escherichia coli isolated from various sources. Mag Al-Kufa Univ Biol. 2025;17(1); 53–63https://doi.org/10.36772/mkub.2025.17.1
39. Hamid SAA, Khoshabeh RM. Antibiotic resistance, biofilm formation, and identification of FimH and FimA adhesion genes in uropathogenic Escherichia coli (UPEC) isolated from patients in Baghdad province. Iraqi J Sc. 2024;65(10):5546–5554. https://doi:10.24996/ijs.2024.65.10.1
40. Aziz SN, Al Marjani MF. Investigation of bacterial persistence and filament formation in clinical Klebsiella pneumoniae. ARO Sci J Koya Univ. 2022;10(2):82– 86. https://doi.org/10.14500/aro.10895
41. Zhao J, Zhang Y, Li X, Chen X, Wang L, Sun H. Escherichia coli toxin gene hipA affects biofilm formation and DNA release. Microbiology. 2013;159(3):633–640. https://doi.org/10.1099/mic.0.063784-0
42. Karimi S, Hashemi A, Soleimani S, Javan-Nikkhah M, Shahraki-Esfahani E. Association between toxin-antitoxin systems and biofilm formation. Jundishapur J Microbiol. 2014;8(1):e14540. https://doi.org/10.5812/jjm.14540
43. Zhuang Y, Chen W, Yao F, Huang Y, Zhou S, Li H, Peng X. Short-term pretreatment of sub-inhibitory concentrations of gentamicin inhibits the swarming motility of Escherichia coli by down-regulating the succinate dehydrogenase gene. Cell Physiol Biochem. 2016;39(4):1307–1316. https://doi.org/10.1159/000447835.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ibn AL-Haitham Journal For Pure and Applied Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
licenseTermsHow to Cite
